MIRA-1, p53 inducer

Be the first to review this product! Submit a review

|

(0 Publication)

MW 183.16 Da, Purity >99%. Novel, nontoxic and selective p53 inducer. Antitumor agent. Promotes tumor cell apoptosis in a mutant p53-dependent manner (IC₅₀ = 10 μM) and prolongs survival. Active in vivo and in vitro.

View Alternative Names

AHDC, ALDC, ALDH 1, ALDH 11, ALDH class 1, ALDH class 2, ALDH-E1, ALDH-E2, ALDHI, ALDM, ALHDII, Acetaldehyde dehydrogenase 1, Acetaldehyde dehydrogenase 2, Aldehyde dehydrogenase 1, Aldehyde dehydrogenase 1 family member A1, Aldehyde dehydrogenase 1 soluble, Aldehyde dehydrogenase 1A1, Aldehyde dehydrogenase 2 family, Aldehyde dehydrogenase 2 family (mitochondrial), Aldehyde dehydrogenase cytosolic, Aldehyde dehydrogenase liver cytosolic, Aldehyde dehydrogenase mitochondrial, Aldh, DKFZp686C2056, DNA helicase, DNA helicase, RecQ like type 3, Exonuclease WRN, HGNC 12791, Liver mitochondrial ALDH, MGC1806, MGC2318, Mitochondrial aldehyde dehydrogenase 2, Nucleus encoded mitochondrial aldehyde dehydrogenase 2, OTTHUMP00000225301, PUMB 1, RALDH 1, RECQL 2, RECQL 3, RecQ protein-like 2, RecQ-like type 3, RecQ3, Retinal dehydrogenase 1, Retinaldehyde dehydrogenase 1, WRN_HUMAN, Werner syndrome ATP-dependent helicase, Werner syndrome helicase, Werner syndrome protein, Werner syndrome, RecQ helicase like